Domů › Srdeční selhání › Texas › Houston
Klinické studie Srdeční selhání v Houston, TX
36 studií pro Srdeční selhání hledá účastníky v lokalitách v Houston a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Probíhá náborFáze 3
- Research Site, Houston
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Probíhá náborFáze 3
- The Methodist Hospital Research Institute, Houston
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Probíhá náborFáze 2
- East Texas Cardiology PA, Houston
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Probíhá náborFáze 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Humble · Vzdálenost 17 mi
BiVACOR® Total Artificial Heart Early Feasibility Study
Probíhá nábor
- Texas Heart Institute / Baylor St. Luke's Medical Center, Houston
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Probíhá náborFáze 3
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
A Study of LY3971297 in Participants With Heart Failure
Probíhá náborFáze 1
- Houston Methodist Hospital, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Probíhá náborFáze 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- a dalších 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Probíhá náborFáze 3
- Research Site, Houston
- Research Site, Houston
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Probíhá náborFáze 3
- CON-10085, Houston, TX, Houston
- Houston, TX Investigative Site CON-10320, Houston
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
Probíhá náborObservační studie
- Methodist DeBakey Heart and Vascular Center, Houston
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Probíhá náborFáze 3
- Houston, TX Investigative Site 10085, Houston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Probíhá nábor
- Houston Methodist Hospital, Houston
- Memorial Hermann-Texas Medical Center, Houston
- Texas Heart Institute at Baylor St. Luke's Medical Center, Houston
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Probíhá náborFáze 2
- Local Institution - 151, Houston
- Local Institution - 157, Houston
- Local Institution - 163, Houston
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Probíhá náborFáze 2/3
- Texas Children's Hospital ( Site 0039), Houston
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Probíhá náborFáze 2
- Center for Advanced Heart Failure, Houston
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
Probíhá náborObservační studie
- Texas Children's Hospital, Houston
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Probíhá nábor
- Texas Heart Institute, Houston
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Probíhá náborObservační studie
- Houston, Houston
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Probíhá náborObservační studie
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- BI Research Center, Houston
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Probíhá náborFáze 3
- Tenax Investigational Site, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Probíhá náborFáze 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- a dalších 1
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Probíhá nábor
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Assessment of CCM in HF With Higher Ejection Fraction
Probíhá nábor
- Baylor College of Medicine, Houston
- Houston Methodist, Houston
- Memorial Hermann Texas Medical Center, Houston
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Probíhá náborFáze 3
- FIN-10085, Houston, TX, Houston
18F-mFBG Imaging for Myocardial Sympathetic Innervation
Probíhá náborFáze 2
- UT Health Houston, Houston
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Probíhá náborFáze 3
- Texas Children's Hospital - Cardiology, Houston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Probíhá nábor
- Baylor/Texas Heart, Houston
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Probíhá náborFáze 3
- Texas Children's Hospital - Cardiology, Houston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Probíhá nábor
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
- Houston Methodist, Houston
- UTHealth Memorial Hermann, Houston
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
Probíhá náborObservační studie
- Baylor College of Medicine, Houston
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Probíhá nábor
- Houston Healthcare Medical Center, Houston
Left vs Left Randomized Clinical Trial
Probíhá nábor
- Baylor College of Medicine, Houston
Cardiogenic Shock Working Group Registry
Probíhá náborObservační studie
- Houston Methodist Hospital, Houston
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
Probíhá náborFáze 1
- Texas Heart Institute, Houston
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Probíhá náborObservační studie
- Houston Methodist DeBakey Heart and Vascular Center, Houston
Studie Srdeční selhání v jiných městech
- New York City, NY51 studií
- Boston, MA44 studií
- Dallas, TX42 studií
- Cleveland, OH33 studií
- Chicago, IL31 studií
- Philadelphia, PA31 studií
- San Francisco, CA29 studií
- St. Louis, MO26 studií
- Durham, NC26 studií
- Kansas City, MO25 studií
- Atlanta, GA25 studií
- Baltimore, MD24 studií
Další studie v Houston
- Nemalobuněčný plicní karcinom145 studií
- Rakovina prsu126 studií
- Rakovina (všechny typy)121 studií
- Metastatický karcinom104 studií
- Kolorektální karcinom102 studií
- Rakovina vaječníků89 studií
- Akutní myeloidní leukemie85 studií
- Rakovina plic78 studií
- Rakovina prostaty76 studií
- Rakovina endometria68 studií
- Rakovina slinivky břišní61 studií
- Melanom59 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.